Pulmonary tuberculosis and nutritional vulnerability during anti-tumor necrosis factor therapy for inflammatory bowel disease: Two case reports

Table 1 Comprehensive nutritional assessment and clinical summary of cases

Parameter	Case 1	Case 2	Reference/threshold
Anthropometric and clinical characteristics
Height (cm)	163	170	-
Pre-illness body weight (kg)	53	54	-
Body weight at presentation (kg)	46	51	-
BMI at presentation (kg/m²)	17.3	17.6	18.5-24.9
Unintentional weight loss (%)	13.20	5.60	≥ 5% clinically significant
MNA-SF
A: Food intake decline in past 3 months (0-2)	1	0
B: Weight loss in past 3 months (0-3)	0	2
C: Mobility (0-2)	2	2
D: Psychological stress/acute disease (0-2)	0	0
E: Neuropsychological problems (0-2)	2	2
F: BMI	0	0
MNA-SF total score	5	6	12-14 = normal
MNA-SF nutritional status	Malnourished	Malnourished	0-7 = malnourished
Nutrient intake (24-hour dietary recall)
Energy (kcal/day)	1620.7	1241	2000-2200
Protein (g/day)	62.1	19.7	46-50 g/day
Protein (g/kg body weight/day)	1.35	0.39	≥ 1.2 (IBD guideline)
Dietary fiber (g/day)	15.6	10.9	25-28 g/day
Iron (mg/day)	8.5	4.6	18 mg/day
Calcium (mg/day)	573.1	410.5	1000 mg/day
Vitamin B12 (μg/day)	4.7	1	2.4 μg/day

MNA-SF: Mini Nutritional Assessment-Short Form; IBD: Inflammatory bowel disease; BMI: Body mass index.